Rosetta Genomics Completes $4.5M Financing

Rosetta plans to use the proceeds for general corporate purposes and to support the development of its microRNA-based diagnostic pipeline.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.